Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason I Herschkowitz

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Breast Cancer Research and Treatment|October 5, 2010
MPA-induced gene expression and stromal and parenchymal gene expression profiles in luminal murine mammary carcinomas with different hormonal requirementsSebastián Giulianelli, Jason I Herschkowitz, Vyomesh Patel, et al.
Molecular Cancer|April 9, 2008
Molecular analysis reveals heterogeneity of mouse mammary tumors conditionally mutant for Brca1Mollie H Wright, Ana I Robles, Jason I Herschkowitz, et al.
Disease Models & Mechanisms|May 7, 2016
Genomic profiling of murine mammary tumors identifies potential personalized drug targets for p53-deficient mammary cancersAdam D Pfefferle, Yash N Agrawal, Daniel C Koboldt, et al.
Cell Death & Disease|March 3, 2022
Loss of function of BRCA1 promotes EMT in mammary tumors through activation of TGFβR2 signaling pathwayFeng Bai, Chuying Wang, Xiong Liu, et al.
Cell Cycle (Georgetown, Tex.)|April 20, 2011
RB1 and p53 at the crossroad of EMT and triple-negative breast cancerZhe Jiang, Robert Jones, Jeff C Liu, et al.
Journal of Cellular Biochemistry|January 8, 2020
Long noncoding RNA BHLHE40-AS1 promotes early breast cancer progression through modulating IL-6/STAT3 signalingRebecca S DeVaux, Ali S Ropri, Sandra L Grimm, et al.
The Journal of Clinical Investigation|August 4, 2010
Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 statusZhe Jiang, Tao Deng, Robert Jones, et al.
Small (Weinheim an Der Bergstrasse, Germany)|May 26, 2017
Inertial Microfluidic Cell Stretcher (iMCS): Fully Automated, High-Throughput, and Near Real-Time Cell MechanotypingYanxiang Deng, Steven P Davis, Fan Yang, et al.
Cancer Research|September 21, 2014
BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor developmentFeng Bai, Ho Lam Chan, Alexandria Scott, et al.
Cancer Research|May 27, 2010
Fibroblast growth factor receptor signaling dramatically accelerates tumorigenesis and enhances oncoprotein translation in the mouse mammary tumor virus-Wnt-1 mouse model of breast cancerAdam C Pond, Jason I Herschkowitz, Kathryn L Schwertfeger, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Breast Cancer Research and Treatment|October 5, 2010
MPA-induced gene expression and stromal and parenchymal gene expression profiles in luminal murine mammary carcinomas with different hormonal requirementsSebastián Giulianelli, Jason I Herschkowitz, Vyomesh Patel, et al.
Molecular Cancer|April 9, 2008
Molecular analysis reveals heterogeneity of mouse mammary tumors conditionally mutant for Brca1Mollie H Wright, Ana I Robles, Jason I Herschkowitz, et al.
Disease Models & Mechanisms|May 7, 2016
Genomic profiling of murine mammary tumors identifies potential personalized drug targets for p53-deficient mammary cancersAdam D Pfefferle, Yash N Agrawal, Daniel C Koboldt, et al.
Cell Death & Disease|March 3, 2022
Loss of function of BRCA1 promotes EMT in mammary tumors through activation of TGFβR2 signaling pathwayFeng Bai, Chuying Wang, Xiong Liu, et al.
Cell Cycle (Georgetown, Tex.)|April 20, 2011
RB1 and p53 at the crossroad of EMT and triple-negative breast cancerZhe Jiang, Robert Jones, Jeff C Liu, et al.
Journal of Cellular Biochemistry|January 8, 2020
Long noncoding RNA BHLHE40-AS1 promotes early breast cancer progression through modulating IL-6/STAT3 signalingRebecca S DeVaux, Ali S Ropri, Sandra L Grimm, et al.
The Journal of Clinical Investigation|August 4, 2010
Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 statusZhe Jiang, Tao Deng, Robert Jones, et al.
Small (Weinheim an Der Bergstrasse, Germany)|May 26, 2017
Inertial Microfluidic Cell Stretcher (iMCS): Fully Automated, High-Throughput, and Near Real-Time Cell MechanotypingYanxiang Deng, Steven P Davis, Fan Yang, et al.
Cancer Research|September 21, 2014
BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor developmentFeng Bai, Ho Lam Chan, Alexandria Scott, et al.
Cancer Research|May 27, 2010
Fibroblast growth factor receptor signaling dramatically accelerates tumorigenesis and enhances oncoprotein translation in the mouse mammary tumor virus-Wnt-1 mouse model of breast cancerAdam C Pond, Jason I Herschkowitz, Kathryn L Schwertfeger, et al.
Pageof 5